Longitudinal magnetic resonance imaging vascular changes, apolipoprotein e genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study

American Journal of Geriatric Psychiatry

Volumn 15, Issue 10, 2007, Pages 839-849

  Steffens, David C ^a,c   Potter, Guy G ^a,c   Mcquoid, Douglas R ^a   Macfall, James R ^a   Payne, Martha E ^a   Burke, James R ^b,c   Plassman, Brenda L ^a   Welsh Bohmer, Kathleen A ^a,c  

^a Department of Psychiatry and Behavioral Sciences ^*  (United States)

^b Division of Neurology   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

AGED; ALGORITHM; ALLELE; ARTICLE; BLOOD SAMPLING; BRAIN SIZE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DEPRESSION; FEMALE; FOLLOW UP; GENOTYPE; GRAY MATTER; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; WHITE MATTER; AGE; BRAIN; COMPARATIVE STUDY; CONSENSUS; DISEASE COURSE; GENETICS; GERIATRIC ASSESSMENT; IMAGE PROCESSING; MAJOR DEPRESSION; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PREVALENCE; STATISTICS;

AGE FACTORS; AGED; APOLIPOPROTEIN E4; BRAIN; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; CONSENSUS; DEMENTIA; DEMENTIA, VASCULAR; DEPRESSIVE DISORDER, MAJOR; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; GERIATRIC ASSESSMENT; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PREVALENCE;

EID: 38449110435     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e318048a1a0     Document Type: Article

References (54)

1. Geerlings MI, Schmand B, Braam AW, et al: Depressive symptoms and risk of Alzheimer's disease in more highly educated older people. J Am Geriatr Soc 2000; 48:1092-1097
2. Wilson RS, Barnes LL, Mendes de Leon CF, et al: Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology 2002; 59:364-370
3. Green RC, Cupples LA, Kurz A, et al: Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch Neurol 2003; 60:753-759
4. Modrego PJ, Ferrandez J: Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. Arch Neurol 2004; 61:1290-1293
5. Steffens DC, Plassman BL, Helms MJ, et al: A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease. Biological Psychiatry 1997; 41:851-856
6. Berger AK, Fratiglioni L, Forsell Y, et al: The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology 1999; 53:1998-2002
7. Chen P, Ganguli M, Mulsant BH, et al: The temporal relationship between depressive symptoms and dementia: a community-based prospective study. Arch Gen Psychiatry 1999; 56:261-266
8. Kales HC, Maixner DF, Mellow AM: Cerebrovascular disease and late-life depression. Am J Geriatr Psychiatry 2005; 13:88-98
9. de Groot JC, de Leeuw FE, Oudkerk M, et al: Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol 2002; 52:335-341
10. Steffens DC, MacFall JR, Payne ME, et al: Grey-matter lesions and dementia. Lancet 2000; 356:1686-1687
11. Mungas D, Harvey D, Reed BR, et al: Longitudinal volumetric MRI change and rate of cognitive decline. Neurology 2005; 65:565-571
12. Garde E, Lykke Mortensen E, Rostrup E, et al: Decline in intelligence is associated with progression in white matter hyperintensity volume. J Neurol Neurosurg Psychiatry 2005; 76:1289-1291
13. Steffens DC, Welsh-Bohmer KA, Burke JR, et al: Methodology and preliminary results from the neurocognitive outcomes of depression in the elderly study. J Geriatr Psychiatry Neurol 2004; 17:202-211
14. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:55-61
15. Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134:382-389
16. Landerman R, George LK, Campbell RT, et al: Alternative models of the stress buffering hypothesis. Am J Comm Psychol 1989; 17:626-642
17. Robins N, Helzer JE, Croughan J, et al: National Institute of Mental Health diagnostic interview schedule. Arch Gen Psychiatry 1981; 38:381-389
18. Hays JC, Steffens DC, Flint EP, et al: Does social support buffer functional decline in elderly patients with unipolar depression? Am J Psychiatry 2001; 158:1850-1855
19. Steffens DC, McQuoid DR, Krishnan KRR: The Duke somatic treatment algorithm for geriatric depression (STAGED) approach. Psychopharmacol Bull 2002; 36:58-68
20. Tschanz JT, Welsh-Bohmer KA, Skoog I, et al: Dementia diagnoses from clinical and neuropsychological data compared: the Cache County study. Neurology 2000; 54:1290-1296
21. Morris JC, Heyman A, Mohs RC, et al: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989; 39:1159-1165
22. Wechsler D: Wechsler Memory Scale-Revised Manual. San Antonio, Psychological Corporation, 1987
23. Benton A: Revised Visual Retention Test - 4th Edition. New York, The Psychological Corporation, 1974
24. Benton AL, Hamsher K, Varney N, et al: Contributions to Neuropsychological Assessment. New York, Oxford University Press, 1983
25. Reitan RM: Trail Making Test: Manual for Administration and Scoring. Tucson, Reitan Neuropsychological Laboratory, 1992
26. Smith A: Symbol Digit Modalities Test-Manual. Los Angeles, Western Psychological Services, 1982
27. Wechsler D: The Wechsler Adult Intelligence Scale Revised. New York, The Psychological Corporation, 1981
28. Hoppe CD, Muller UD, Werheid KD, et al: Digit Ordering Test: clinical, psychometric, and experimental evaluation of a verbal working memory test. Clin Neuropsychol 2000; 14:38-55
29. Zachary RA: Shipley Institute of Living Scale - Revised Manual. Los Angeles, Western Psychological Services, 1991
30. Clark CM, Ewbank DC: Performance of the dementia severity rating scale: a caregiver questionnaire for rating severity in Alzheimer disease. Alzheimer Dis Assoc Dis 1996; 10:31-39
31. Breitner JCS, Welsh KA, Gau BA, et al: Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of aging twin veterans. III. Detection of cases, longitudinal results, and observations on twin concordance. Arch Neurol 1995; 52:763-771
32. Breitner JC, Wyse BW, Anthony JC, et al: APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. Neurology 1999; 53:321-331
33. Langa KM, Plassman BL, Wallace RB, et al: The Aging, Demographics, and Memory Study: study design and methods. Neuroepidemiology 2005; 25:181-191
34. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task force on Alzheimer's disease. Neurology 1984; 34:939-944
35. Roman GC, Tatemichi TK, Erkinjuntti T, et al: Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43:250-260
36. Petersen RC, Smith GE, Waring SC, et al: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56:303-308
37. Graham JE, Rockwood K, Beattie BL, et al: Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997; 349:1793-1796
38. Payne ME, Fetzer DL, MacFall JR, et al: Development of a semi-automated method for quantification of MRI gray and white matter lesions in geriatric subjects. Psychiatry Res 2002; 115:63-77
39. Saunders AM, Strittmatter WJ, Schmechel D, et al: Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43:1467-1472
40. Devanand DP, Sano M, Tang MX, et al: Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry 1996; 53:175-182
41. Tuokko H, Frerichs R, Graham J, et al: Five-year follow-up of cognitive impairment with no dementia. Arch Neurol 2003; 60:577-582
42. Lee JS, Potter GG, Wagner HR, et al: Persistent mild cognitive impairment in geriatric depression. Int Psychogeriatr 2007; 19:125-135
43. Geda YE, Knopman DS, Mrazek DA, et al: Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study. Arch Neurol 2006; 63:435-440
44. Ganguli M, Du Y, Dodge HH, et al: Depressive symptoms and cognitive decline in late life: a prospective epidemiological study. Arch Gen Psychiatry 2006; 63:153-160
45. Radloff LS: The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1:385-401
46. Schmidt R, Fazekas F, Kapeller P, et al: MRI white matter hyperintensities: three year follow-up of the Austrian Stroke Prevention Study. Neurology 1999; 53:132-139
47. Longstreth WT Jr, Arnold AM, Beauchamp, NJ et al: Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 2005; 36:56-61
48. Schmidt R, Ropele S, Enzinger C, et al: White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study. Ann Neurol 2005; 58:610-616
49. Terai S: A neuroradiological study on the influence of cerebral atrophy and white matter lesion on cognitive function in the elderly. Nippon Ronen Igakkai Zasshi 2004; 41:521-527
50. Butters MA, Sweet RA, Mulsant BH, et al: APOE is associated with age-of-onset, but not cognitive functioning, in late-life depression. Int J Geriatr Psychiatry 2003; 18:1075-1081
51. Alexopoulos GS, Meyers BS, Young RC, et al: 'Vascular depression' hypothesis. Arch Gen Psychiatry 1997; 54:915-922
52. Steffens DC, Krishnan KRR: Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol Psychiatry 1998; 43:705-712
53. Nakata-Kudo Y, Mizuno T, Yamada K, et al: Microbleeds in Alzheimer disease are more related to cerebral amyloid angiopathy than cerebrovascular disease. Dement Geriatr Cogn Disord 2006; 22:8-14
54. Steffens DC, Otey E, Alexopoulos GS, et al: Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch Gen Psychiatry 2006; 63:130-138